CA1053152A - Isolation and purification of e. coli enterotoxin - Google Patents
Isolation and purification of e. coli enterotoxinInfo
- Publication number
- CA1053152A CA1053152A CA238,673A CA238673A CA1053152A CA 1053152 A CA1053152 A CA 1053152A CA 238673 A CA238673 A CA 238673A CA 1053152 A CA1053152 A CA 1053152A
- Authority
- CA
- Canada
- Prior art keywords
- coli
- enterotoxin
- gel
- labile
- serotype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1467174A CH612994A5 (en) | 1974-11-01 | 1974-11-01 | Process for the preparation of coli enterotoxin |
| CH1645874 | 1974-12-11 | ||
| CH1645974 | 1974-12-11 | ||
| CH604075A CH615196A5 (en) | 1975-05-12 | 1975-05-12 | Purification process for coli enterotoxin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1053152A true CA1053152A (en) | 1979-04-24 |
Family
ID=27428963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA238,673A Expired CA1053152A (en) | 1974-11-01 | 1975-10-30 | Isolation and purification of e. coli enterotoxin |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS5170810A (cs) |
| AU (1) | AU511934B2 (cs) |
| CA (1) | CA1053152A (cs) |
| DD (1) | DD124879A5 (cs) |
| DE (1) | DE2547224A1 (cs) |
| DK (2) | DK478575A (cs) |
| ES (1) | ES442242A1 (cs) |
| FI (2) | FI752964A7 (cs) |
| FR (1) | FR2289206A1 (cs) |
| GB (1) | GB1529871A (cs) |
| IE (1) | IE43702B1 (cs) |
| IL (1) | IL48384A (cs) |
| NL (1) | NL7512590A (cs) |
| NO (1) | NO753578L (cs) |
| NZ (1) | NZ179108A (cs) |
| SE (1) | SE8100404L (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4740585A (en) * | 1984-07-30 | 1988-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Synthetic vaccine against urinary infections |
| IL78775A (en) * | 1985-05-15 | 1992-06-21 | Biotech Australia Pty Ltd | Oral vaccines |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA738364B (en) * | 1972-12-04 | 1974-09-25 | Rit Rech Ind Therapeut | Piglet colibacillosis vaccines and process for their preparation |
-
1975
- 1975-10-22 DE DE19752547224 patent/DE2547224A1/de not_active Ceased
- 1975-10-23 DK DK478575A patent/DK478575A/da unknown
- 1975-10-23 FI FI752964A patent/FI752964A7/fi not_active Application Discontinuation
- 1975-10-24 NO NO753578A patent/NO753578L/no unknown
- 1975-10-28 GB GB44308/75A patent/GB1529871A/en not_active Expired
- 1975-10-28 NL NL7512590A patent/NL7512590A/xx not_active Application Discontinuation
- 1975-10-29 IE IE2352/75A patent/IE43702B1/en unknown
- 1975-10-30 IL IL48384A patent/IL48384A/xx unknown
- 1975-10-30 NZ NZ179108A patent/NZ179108A/xx unknown
- 1975-10-30 ES ES442242A patent/ES442242A1/es not_active Expired
- 1975-10-30 CA CA238,673A patent/CA1053152A/en not_active Expired
- 1975-10-30 DD DD189144A patent/DD124879A5/xx unknown
- 1975-10-31 JP JP50132085A patent/JPS5170810A/ja active Pending
- 1975-10-31 FR FR7533471A patent/FR2289206A1/fr active Granted
- 1975-11-03 AU AU86282/75A patent/AU511934B2/en not_active Expired
-
1978
- 1978-06-20 DK DK278478A patent/DK278478A/da unknown
- 1978-09-14 FI FI782827A patent/FI782827A7/fi not_active Application Discontinuation
-
1981
- 1981-01-23 SE SE8100404A patent/SE8100404L/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2547224A1 (de) | 1976-05-13 |
| IE43702B1 (en) | 1981-05-06 |
| FI782827A7 (fi) | 1978-09-14 |
| GB1529871A (en) | 1978-10-25 |
| DK278478A (da) | 1978-06-20 |
| IL48384A0 (en) | 1976-03-31 |
| NZ179108A (en) | 1978-07-28 |
| IL48384A (en) | 1979-05-31 |
| SE8100404L (sv) | 1981-01-23 |
| DD124879A5 (cs) | 1977-03-16 |
| FR2289206B1 (cs) | 1978-11-10 |
| NO753578L (cs) | 1976-05-04 |
| ES442242A1 (es) | 1977-08-01 |
| IE43702L (en) | 1976-05-01 |
| AU8628275A (en) | 1977-05-12 |
| NL7512590A (en) | 1976-05-04 |
| AU511934B2 (en) | 1980-09-11 |
| JPS5170810A (cs) | 1976-06-18 |
| DK478575A (da) | 1976-05-02 |
| FR2289206A1 (fr) | 1976-05-28 |
| FI752964A7 (cs) | 1976-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alderete et al. | Purification and chemical characterization of the heat-stable enterotoxin produced by porcine strains of enterotoxigenic Escherichia coli | |
| Daniel et al. | Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties | |
| Belisle et al. | Fatty acids of Treponema pallidum and Borrelia burgdorferi lipoproteins | |
| Kunkel et al. | Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli | |
| JP2761849B2 (ja) | ポリヌクレオチド配列、組換えｄｎａ分子および形質転換体宿主 | |
| Finkelstein et al. | Pathogenesis of experimental cholera: preparation and isolation of choleragen and choleragenoid | |
| Andrews et al. | Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge | |
| Lai et al. | The Chemistry and Biology of Cholera Toxi | |
| US6177085B1 (en) | Generation of immune response using immunogenic conjugate of molecules | |
| Zollinger et al. | Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans | |
| US4123427A (en) | Method for the purification of mycobacterial protein antigens and resulting product | |
| Lyampert et al. | Study on streptococcus group A antigens common with heart tissue elements | |
| AU641711B2 (en) | Process for purification of a 69 000 dalton antigenetic protein from bordetella pertussis | |
| JPH0351692B2 (cs) | ||
| IE51133B1 (en) | E.coli heat stable enterotoxin derivatives and preparation thereof | |
| CA1053152A (en) | Isolation and purification of e. coli enterotoxin | |
| Klipstein et al. | Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin | |
| Gupta et al. | Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs | |
| Stemshorn et al. | The bovine immune response to Brucella abortus I. A water soluble antigen precipitated by sera of some naturally infected cattle | |
| Kamp et al. | Purification of a heat labile dermonecrotic toxin from culture fluid of Pasteurella multocida | |
| Holper et al. | Further studies on multiplication, serology and antigenicity of 2060 and JH viruses | |
| CA1128860A (en) | Peptide complexes of dna-containing organisms | |
| Wisseman Jr et al. | Gross and microscopic skin reactions to killed typhus rickettsiae in human beings | |
| Semprevivo | Exometabolites of Leishmania donovani promastigotes. I. Isolation and initial characterization | |
| Knight et al. | In vitro tests for the measurement of veterinary clostridial toxins, toxoids and antisera: I. Titration of clostridium septicum toxins and antitoxins in cell culture |